122 related articles for article (PubMed ID: 9435152)
1. Models of interaction between metabolic genes and environmental exposure in cancer susceptibility.
Taioli E; Zocchetti C; Garte S
Environ Health Perspect; 1998 Feb; 106(2):67-70. PubMed ID: 9435152
[TBL] [Abstract][Full Text] [Related]
2. Gene--environment interactions in the application of biomarkers of cancer susceptibility in epidemiology.
Garte S; Zocchetti C; Taioli E
IARC Sci Publ; 1997; (142):251-64. PubMed ID: 9354924
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 genetic polymorphism and polycyclic aromatic hydrocarbons on pulmonary function in the elderly: haplotype-based approach for gene-environment interaction.
Choi YH; Kim JH; Hong YC
Toxicol Lett; 2013 Aug; 221(3):185-90. PubMed ID: 23816456
[TBL] [Abstract][Full Text] [Related]
4. The role of individual susceptibility in cancer burden related to environmental exposure.
Bartsch H; Hietanen E
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):569-77. PubMed ID: 8781385
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
Nakachi K; Imai K; Hayashi S; Kawajiri K
Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
[TBL] [Abstract][Full Text] [Related]
7. Interaction between dose and susceptibility to environmental cancer: a short review.
Hietanen E; Husgafvel-Pursiainen K; Vainio H
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):749-54. PubMed ID: 9255556
[TBL] [Abstract][Full Text] [Related]
8. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
Pavanello S; Clonfero E
G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
[TBL] [Abstract][Full Text] [Related]
9. Structure of epidemiological studies on genetic susceptibility to environmental toxicants.
Taioli E
Toxicol Lett; 2002 Feb; 127(1-3):315-9. PubMed ID: 12052672
[TBL] [Abstract][Full Text] [Related]
10. CYP1A1 modifies the effect of maternal exposure to environmental tobacco smoke on child behavior.
Hsieh CJ; Jeng SF; Su YN; Liao HF; Hsieh WS; Wu KY; Chen PC
Nicotine Tob Res; 2010 Nov; 12(11):1108-17. PubMed ID: 20855412
[TBL] [Abstract][Full Text] [Related]
11. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms.
Sugimura T; Kumimoto H; Tohnai I; Fukui T; Matsuo K; Tsurusako S; Mitsudo K; Ueda M; Tajima K; Ishizaki K
J Oral Pathol Med; 2006 Jan; 35(1):11-8. PubMed ID: 16393248
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 1A1 genetic polymorphisms as cancer biomarkers.
Bag A; Jyala NS; Bag N
Indian J Cancer; 2015; 52(4):479-89. PubMed ID: 26960452
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the CYP1A1 gene polymorphism and smoking in non-small cell lung cancer susceptibility.
Xie YQ; Chen JM; Liu Y
Genet Mol Res; 2016 Jan; 14(4):19411-7. PubMed ID: 26782595
[TBL] [Abstract][Full Text] [Related]
14. [Application of the interaction models between the polymorphism(s) of metabolic gene(s) and environmental exposure].
Shen J; Wang R; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):61-4. PubMed ID: 11860849
[TBL] [Abstract][Full Text] [Related]
15. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.
Raimondi S; Boffetta P; Anttila S; Bröckmoller J; Butkiewicz D; Cascorbi I; Clapper ML; Dragani TA; Garte S; Gsur A; Haidinger G; Hirvonen A; Ingelman-Sundberg M; Kalina I; Lan Q; Leoni VP; Le Marchand L; London SJ; Neri M; Povey AC; Rannug A; Reszka E; Ryberg D; Risch A; Romkes M; Ruano-Ravina A; Schoket B; Spinola M; Sugimura H; Wu X; Taioli E
Mutat Res; 2005 Dec; 592(1-2):45-57. PubMed ID: 16009381
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
Ishibe N; Hankinson SE; Colditz GA; Spiegelman D; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
Cancer Res; 1998 Feb; 58(4):667-71. PubMed ID: 9485019
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients.
Dolzan V; Rudolf Z; Breskvar K
Pflugers Arch; 2000; 439(3 Suppl):R29-30. PubMed ID: 10653131
[TBL] [Abstract][Full Text] [Related]
18. Gene-environment interaction in tobacco-related cancers.
Taioli E
Carcinogenesis; 2008 Aug; 29(8):1467-74. PubMed ID: 18550573
[TBL] [Abstract][Full Text] [Related]
19. Smoking habit and genetic factors associated with lung cancer in a population highly exposed to arsenic.
Adonis M; Martínez V; Marín P; Berrios D; Gil L
Toxicol Lett; 2005 Oct; 159(1):32-7. PubMed ID: 16099114
[TBL] [Abstract][Full Text] [Related]
20. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
